From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial
Group
FAS
ORR
PPS
n
Control group
87
65.51 ± 35.59
82
66.26 ± 35.65
IFNα1b group
76
76.87 ± 25.15
69
77.16 ± 24.19
P
0.037
0.033